Annual CFI
-$15.00 K
-$212.00 K-107.61%
31 December 2023
Summary:
Windtree Therapeutics annual cash flow from investing activities is currently -$15.00 thousand, with the most recent change of -$212.00 thousand (-107.61%) on 31 December 2023. During the last 3 years, it has risen by +$276.00 thousand (+94.85%). WINT annual CFI is now -100.11% below its all-time high of $13.80 million, reached on 31 December 2019.WINT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
+$12.00 K+100.00%
30 September 2024
Summary:
Windtree Therapeutics quarterly cash flow from investing activities is currently $0.00, with the most recent change of +$12.00 thousand (+100.00%) on 30 September 2024. Over the past year, it has increased by +$15.00 thousand (+100.00%). WINT quarterly CFI is now -100.00% below its all-time high of $16.26 million, reached on 30 September 2005.WINT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$12.00 K
+$15.00 K+55.56%
30 September 2024
Summary:
Windtree Therapeutics TTM cash flow from investing activities is currently -$12.00 thousand, with the most recent change of +$15.00 thousand (+55.56%) on 30 September 2024. Over the past year, it has increased by +$3000.00 (+20.00%). WINT TTM CFI is now -100.05% below its all-time high of $23.58 million, reached on 30 June 2006.WINT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WINT Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -107.6% | +100.0% | +20.0% |
3 y3 years | +94.8% | +100.0% | +96.8% |
5 y5 years | +99.9% | -100.0% | -109.8% |
WINT Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -107.6% | +94.8% | -100.0% | +100.0% | -106.1% | +96.8% |
5 y | 5 years | -100.1% | +99.9% | -100.0% | +100.0% | -100.1% | +96.8% |
alltime | all time | -100.1% | +99.9% | -100.0% | +100.0% | -100.0% | +100.0% |
Windtree Therapeutics Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $0.00(-100.0%) | -$12.00 K(-55.6%) |
June 2024 | - | -$12.00 K(<-9900.0%) | -$27.00 K(+80.0%) |
Dec 2023 | -$15.00 K(-107.6%) | $0.00(-100.0%) | -$15.00 K(0.0%) |
Sept 2023 | - | -$15.00 K(<-9900.0%) | -$15.00 K(<-9900.0%) |
June 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
Dec 2022 | $197.00 K(-170.6%) | $0.00(0.0%) | $197.00 K(+720.8%) |
Sept 2022 | - | $0.00(-100.0%) | $24.00 K(-130.4%) |
June 2022 | - | $200.00 K(-6766.7%) | -$79.00 K(-72.0%) |
Mar 2022 | - | -$3000.00(-98.3%) | -$282.00 K(+1.1%) |
Dec 2021 | -$279.00 K(-4.1%) | -$173.00 K(+68.0%) | -$279.00 K(-24.6%) |
Sept 2021 | - | -$103.00 K(+3333.3%) | -$370.00 K(+31.2%) |
June 2021 | - | -$3000.00(<-9900.0%) | -$282.00 K(-3.1%) |
Mar 2021 | - | $0.00(-100.0%) | -$291.00 K(0.0%) |
Dec 2020 | -$291.00 K(-102.1%) | -$264.00 K(+1660.0%) | -$291.00 K(+227.0%) |
Sept 2020 | - | -$15.00 K(+25.0%) | -$89.00 K(-103.5%) |
June 2020 | - | -$12.00 K(-80.6%) | $2.52 M(-81.7%) |
Dec 2019 | $13.80 M(-200.5%) | -$62.00 K(-102.4%) | $13.80 M(>+9900.0%) |
Sept 2019 | - | $2.60 M(-76.0%) | $123.00 K(-105.0%) |
June 2019 | - | $10.84 M(+2449.9%) | -$2.47 M(-81.4%) |
Mar 2019 | - | $425.00 K(-103.1%) | -$13.30 M(-3.1%) |
Dec 2018 | -$13.73 M(>+9900.0%) | -$13.74 M(<-9900.0%) | -$13.73 M(<-9900.0%) |
Sept 2018 | - | $0.00(-100.0%) | $9000.00(0.0%) |
June 2018 | - | $9000.00(>+9900.0%) | $9000.00(-325.0%) |
Mar 2018 | - | $0.00(0.0%) | -$4000.00(-83.3%) |
Dec 2017 | -$24.00 K(-90.6%) | $0.00(0.0%) | -$24.00 K(-78.6%) |
Sept 2017 | - | $0.00(-100.0%) | -$112.00 K(-13.2%) |
June 2017 | - | -$4000.00(-80.0%) | -$129.00 K(-5.8%) |
Mar 2017 | - | -$20.00 K(-77.3%) | -$137.00 K(-46.1%) |
Dec 2016 | -$254.00 K(+35.1%) | -$88.00 K(+417.6%) | -$254.00 K(+139.6%) |
Sept 2016 | - | -$17.00 K(+41.7%) | -$106.00 K(+12.8%) |
June 2016 | - | -$12.00 K(-91.2%) | -$94.00 K(-176.4%) |
Mar 2016 | - | -$137.00 K(-328.3%) | $123.00 K(-165.4%) |
Dec 2015 | -$188.00 K(-75.9%) | $60.00 K(-1300.0%) | -$188.00 K(-46.1%) |
Sept 2015 | - | -$5000.00(-102.4%) | -$349.00 K(+149.3%) |
June 2015 | - | $205.00 K(-145.8%) | -$140.00 K(-80.8%) |
Mar 2015 | - | -$448.00 K(+343.6%) | -$731.00 K(-6.3%) |
Dec 2014 | -$780.00 K(+28.3%) | -$101.00 K(-149.5%) | -$780.00 K(-28.0%) |
Sept 2014 | - | $204.00 K(-152.8%) | -$1.08 M(-21.0%) |
June 2014 | - | -$386.00 K(-22.3%) | -$1.37 M(+39.2%) |
Mar 2014 | - | -$497.00 K(+23.0%) | -$985.00 K(+62.0%) |
Dec 2013 | -$608.00 K(-4.4%) | -$404.00 K(+381.0%) | -$608.00 K(+146.2%) |
Sept 2013 | - | -$84.00 K(<-9900.0%) | -$247.00 K(+3.8%) |
June 2013 | - | $0.00(-100.0%) | -$238.00 K(-61.5%) |
Mar 2013 | - | -$120.00 K(+179.1%) | -$618.00 K(-2.8%) |
Dec 2012 | -$636.00 K(+500.0%) | -$43.00 K(-42.7%) | -$636.00 K(+4.1%) |
Sept 2012 | - | -$75.00 K(-80.3%) | -$611.00 K(+2.2%) |
June 2012 | - | -$380.00 K(+175.4%) | -$598.00 K(+173.1%) |
Mar 2012 | - | -$138.00 K(+666.7%) | -$219.00 K(+106.6%) |
Dec 2011 | -$106.00 K(+5.0%) | -$18.00 K(-71.0%) | -$106.00 K(+20.5%) |
Sept 2011 | - | -$62.00 K(+6100.0%) | -$88.00 K(+63.0%) |
June 2011 | - | -$1000.00(-96.0%) | -$54.00 K(-21.7%) |
Mar 2011 | - | -$25.00 K(<-9900.0%) | -$69.00 K(-31.7%) |
Dec 2010 | -$101.00 K(-104.8%) | $0.00(-100.0%) | -$101.00 K(-36.9%) |
Sept 2010 | - | -$28.00 K(+75.0%) | -$160.00 K(-0.6%) |
June 2010 | - | -$16.00 K(-71.9%) | -$161.00 K(+6.6%) |
Mar 2010 | - | -$57.00 K(-3.4%) | -$151.00 K(-107.2%) |
Dec 2009 | $2.10 M | -$59.00 K(+103.4%) | $2.10 M(-54.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2009 | - | -$29.00 K(+383.3%) | $4.60 M(-23.2%) |
June 2009 | - | -$6000.00(-100.3%) | $5.99 M(-72.8%) |
Mar 2009 | - | $2.19 M(-10.2%) | $22.03 M(+64.9%) |
Dec 2008 | $13.36 M(-167.5%) | $2.44 M(+79.6%) | $13.36 M(+73.9%) |
Sept 2008 | - | $1.36 M(-91.5%) | $7.68 M(-19.1%) |
June 2008 | - | $16.03 M(-347.5%) | $9.49 M(-139.3%) |
Mar 2008 | - | -$6.48 M(+100.4%) | -$24.16 M(+22.0%) |
Dec 2007 | -$19.80 M(-1191.0%) | -$3.23 M(-201.8%) | -$19.80 M(+17.5%) |
Sept 2007 | - | $3.17 M(-118.0%) | -$16.86 M(-17.6%) |
June 2007 | - | -$17.63 M(+733.5%) | -$20.46 M(-1214.3%) |
Mar 2007 | - | -$2.12 M(+634.4%) | $1.84 M(+1.2%) |
Dec 2006 | $1.81 M(-215.0%) | -$288.00 K(-32.4%) | $1.81 M(-73.7%) |
Sept 2006 | - | -$426.00 K(-109.1%) | $6.89 M(-70.8%) |
June 2006 | - | $4.67 M(-318.4%) | $23.58 M(+48.2%) |
Mar 2006 | - | -$2.14 M(-144.6%) | $15.91 M(-1108.2%) |
Dec 2005 | -$1.58 M(-73.1%) | $4.79 M(-70.5%) | -$1.58 M(-877.3%) |
Sept 2005 | - | $16.26 M(-640.6%) | $203.00 K(-102.0%) |
June 2005 | - | -$3.01 M(-84.7%) | -$9.95 M(-60.1%) |
Mar 2005 | - | -$19.62 M(-398.6%) | -$24.92 M(+324.4%) |
Dec 2004 | -$5.87 M(-164.7%) | $6.57 M(+7.5%) | -$5.87 M(-42.6%) |
Sept 2004 | - | $6.11 M(-134.0%) | -$10.23 M(-34.5%) |
June 2004 | - | -$17.98 M(+3005.2%) | -$15.62 M(-399.7%) |
Mar 2004 | - | -$579.00 K(-126.1%) | $5.21 M(-42.6%) |
Dec 2003 | $9.08 M(+287.9%) | $2.21 M(+206.8%) | $9.08 M(+124.1%) |
Sept 2003 | - | $722.00 K(-74.7%) | $4.05 M(-37.7%) |
June 2003 | - | $2.85 M(-13.1%) | $6.50 M(+32.8%) |
Mar 2003 | - | $3.29 M(-216.8%) | $4.90 M(+109.3%) |
Dec 2002 | $2.34 M(-225.6%) | -$2.81 M(-188.5%) | $2.34 M(-1281.8%) |
Sept 2002 | - | $3.18 M(+154.3%) | -$198.00 K(-84.5%) |
June 2002 | - | $1.25 M(+71.8%) | -$1.28 M(-158.9%) |
Mar 2002 | - | $727.00 K(-113.6%) | $2.18 M(-216.8%) |
Dec 2001 | -$1.86 M(-84.4%) | -$5.35 M(-355.6%) | -$1.86 M(-171.0%) |
Sept 2001 | - | $2.09 M(-55.5%) | $2.63 M(-1037.5%) |
June 2001 | - | $4.71 M(-242.1%) | -$280.00 K(-98.2%) |
Mar 2001 | - | -$3.31 M(+284.2%) | -$15.18 M(+27.4%) |
Dec 2000 | -$11.91 M(-594.1%) | -$862.00 K(+6.2%) | -$11.91 M(+23.6%) |
Sept 2000 | - | -$812.00 K(-92.0%) | -$9.64 M(+9.2%) |
June 2000 | - | -$10.19 M(>+9900.0%) | -$8.83 M(-797.2%) |
Mar 2000 | - | -$45.00 K(-103.2%) | $1.27 M(-47.5%) |
Dec 1999 | $2.41 M(+20.5%) | $1.41 M(>+9900.0%) | $2.41 M(+100.9%) |
Sept 1999 | - | $0.00(-100.0%) | $1.20 M(-33.3%) |
June 1999 | - | -$100.00 K(-109.1%) | $1.80 M(+12.5%) |
Mar 1999 | - | $1.10 M(+450.0%) | $1.60 M(-20.0%) |
Dec 1998 | $2.00 M(-71.0%) | $200.00 K(-66.7%) | $2.00 M(-78.7%) |
Sept 1998 | - | $600.00 K(-300.0%) | $9.40 M(+11.9%) |
June 1998 | - | -$300.00 K(-120.0%) | $8.40 M(+6.3%) |
Mar 1998 | - | $1.50 M(-80.3%) | $7.90 M(+14.5%) |
Dec 1997 | $6.90 M(+213.6%) | $7.60 M(-2000.0%) | $6.90 M(+3350.0%) |
Sept 1997 | - | -$400.00 K(-50.0%) | $200.00 K(-83.3%) |
June 1997 | - | -$800.00 K(-260.0%) | $1.20 M(-47.8%) |
Mar 1997 | - | $500.00 K(-44.4%) | $2.30 M(+4.5%) |
Dec 1996 | $2.20 M(-157.9%) | $900.00 K(+50.0%) | $2.20 M(+69.2%) |
Sept 1996 | - | $600.00 K(+100.0%) | $1.30 M(+85.7%) |
June 1996 | - | $300.00 K(-25.0%) | $700.00 K(+75.0%) |
Mar 1996 | - | $400.00 K(>+9900.0%) | $400.00 K(>+9900.0%) |
Dec 1995 | -$3.80 M | - | - |
June 1995 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 1995 | - | $0.00 | $0.00 |
FAQ
- What is Windtree Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Windtree Therapeutics?
- What is Windtree Therapeutics annual CFI year-on-year change?
- What is Windtree Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Windtree Therapeutics?
- What is Windtree Therapeutics quarterly CFI year-on-year change?
- What is Windtree Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Windtree Therapeutics?
- What is Windtree Therapeutics TTM CFI year-on-year change?
What is Windtree Therapeutics annual cash flow from investing activities?
The current annual CFI of WINT is -$15.00 K
What is the all time high annual CFI for Windtree Therapeutics?
Windtree Therapeutics all-time high annual cash flow from investing activities is $13.80 M
What is Windtree Therapeutics annual CFI year-on-year change?
Over the past year, WINT annual cash flow from investing activities has changed by -$212.00 K (-107.61%)
What is Windtree Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of WINT is $0.00
What is the all time high quarterly CFI for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly cash flow from investing activities is $16.26 M
What is Windtree Therapeutics quarterly CFI year-on-year change?
Over the past year, WINT quarterly cash flow from investing activities has changed by +$15.00 K (+100.00%)
What is Windtree Therapeutics TTM cash flow from investing activities?
The current TTM CFI of WINT is -$12.00 K
What is the all time high TTM CFI for Windtree Therapeutics?
Windtree Therapeutics all-time high TTM cash flow from investing activities is $23.58 M
What is Windtree Therapeutics TTM CFI year-on-year change?
Over the past year, WINT TTM cash flow from investing activities has changed by +$3000.00 (+20.00%)